Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,179 | 20,272 | 35,140 | 47,730 | 376,976 |
| Marketable Securities | 267,168 | 188,872 | 30,654 | 220,499 | N/A |
| Receivables | 329 | N/A | N/A | N/A | N/A |
| Inventories | 2,936 | 0 | N/A | N/A | N/A |
| TOTAL | $301,412 | $211,917 | $67,244 | $275,365 | $381,736 |
| Non-Current Assets | |||||
| PPE Net | 1,189 | 651 | 54 | 22,630 | 6,507 |
| Investments And Advances | 0 | 0 | 0 | 15,322 | 0 |
| Other Non-Current Assets | 3,275 | 2,736 | 3,078 | 8,585 | 13,744 |
| TOTAL | $4,464 | $3,387 | $3,132 | $46,537 | $20,251 |
| Total Assets | $305,876 | $215,304 | $70,376 | $321,902 | $401,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,167 | 4,257 | 5,711 | 2,608 | 2,453 |
| Accrued Expenses | 17,020 | 6,149 | 12,803 | 6,390 | 4,208 |
| TOTAL | $21,187 | $10,406 | $18,514 | $13,043 | $12,143 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 350 | 814 | 144,574 | 12,568 | 5,794 |
| TOTAL | $350 | $814 | $144,574 | $12,568 | $5,794 |
| Total Liabilities | $21,537 | $11,220 | $163,088 | $25,611 | $17,937 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,354 | 27,543 | 8,322 | 8,312 | 8,290 |
| Common Shares | 1 | 1 | 10 | 1 | 1 |
| Retained earnings | -227,141 | -145,014 | -95,245 | -242,403 | -141,351 |
| Other shareholders' equity | 242 | 196 | 6 | -1,048 | 0 |
| TOTAL | $284,339 | $204,084 | $-92,712 | $296,291 | $384,050 |
| Total Liabilities And Equity | $305,876 | $215,304 | $70,376 | $321,902 | $401,987 |